openPR Logo
Press release

Familial Adenomatous Polyposis Treatment Market Will Generate Record Revenue by 2028

12-24-2022 06:46 AM CET | Health & Medicine

Press release from: Orion Market Research

Familial Adenomatous Polyposis Treatment Market Will Generate

Familial adenomatous polyposis treatment market is anticipated to grow at a significant CAGR during the forecast period. Familial adenomatous polyposis (FAP) is an inherited disorder. It is characterized by the large intestine (colon) . Additionally, the classic type of familial adenomatous polyposis in people begins to occur as early as in their teenage years causing them to develop multiple noncancerous in the colon. The major factor accelerating the growth of the market is the increasing prevalence of familial adenomatous polyposis across the globe. 

According to the National Organization for Rare Disorders (NORD), FAP affects males and females equally and occurs in approximately one in 5,000 to 10,000 individuals in the US. Additionally, it accounts for about 0.5% of all cases of colorectal cancer. Furthermore, it is estimated that it affects almost 50,000 American families. Moreover, as per the American Society of Clinical Oncology (ASCO), it is estimated that most people with FAP will have multiple colon polyps by age 35 and approximately 30% of people with FAP do not have any family history of the condition. Further, it is estimated that people affected with FAP have a 100% risk of colorectal cancer if polyps are not removed. Hence, the rising prevalence of the disease is driving the demand for familial adenomatous polyposis treatment.

To Request a Sample of our Report on Familial Adenomatous Polyposis Treatment Market:   https://www.omrglobal.com/request-sample/familial-adenomatous-polyposis-treatment-market

Some major players operating in the market include Cancer Prevention Pharmaceuticals Inc, Marina Biotech, Inc, and Thetis Pharmaceuticals LLC, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in June 2020, Cancer Prevention Pharmaceuticals, Inc. announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA). It was aimed to receive accelerated approval for CPP-1X/sul for the treatment of adults with familial adenomatous polyposis (FAP).

Market Coverage

The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028

Segment Covered- 

By Type
By Application

Regions Covered-

North America
Europe
Asia-Pacific
Rest of the World

Competitive Landscape- Cancer Prevention Pharmaceuticals Inc, Marina Biotech Inc, and Thetis Pharmaceuticals LLC, among others. 

Familial Adenomatous Polyposis Treatment Market Report by Segment

By Type

Icosapent
Eflornithine Hydrochloride
Aspirin
CEQ-508 
Others

By Application

Hospital 
Clinics
Others

A full Report of Familial Adenomatous Polyposis Treatment Market is Available @ https://www.omrglobal.com/industry-reports/familial-adenomatous-polyposis-treatment-market

Familial Adenomatous Polyposis Treatment Market Report by Region

North America

United States
Canada

Europe

UK
Germany
Spain
France
Italy
Rest of Europe

Asia-Pacific

India
China
Japan
South Korea
Rest of APAC

Rest of the World

Latin America 
Middle East & Africa

Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

https://sportmsr.com/%d8%b3%d9%88%d9%82-%d8%b9%d9%84%d8%a7%d8%ac-%d8%a3%d9%85%d8%b1%d8%a7%d8%b6-%d8%a7%d9%84%d9%83%d9%84%d9%89-%d9%81%d9%8a-%d8%a7%d9%84%d9%85%d8%b1%d8%ad%d9%84%d8%a9-%d8%a7%d9%84%d9%86%d9%87%d8%a7%d8%a6/
https://revistaeconomiasocial.com/2022/12/23/el-mercado-del-sistema-de-recoleccion-de-energia-sera-testigo-de-la-aceleracion-del-crecimiento-para-2028/
https://citytoday-hildesheim.de/index.php/2022/12/23/energy-harvesting-system-markt-weltweite-branchenanalyse-zukunftige-nachfrage-und-prognose-bis-2028/
https://www.asiatimeskorea.com/news/2028%eb%85%84%ea%b9%8c%ec%a7%80-%ec%97%84%ec%b2%ad%eb%82%9c-%ec%84%b1%ec%9e%a5%ec%9d%84-%eb%b3%b4%ec%9d%bc-%ed%94%84%eb%9e%91%ec%8a%a4-%ed%99%94%ec%9e%a5%ed%92%88-%ed%8f%ac%ec%9e%a5-%ec%8b%9c%ec%9e%a5/199109/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

About Orion Market Research 
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Familial Adenomatous Polyposis Treatment Market Will Generate Record Revenue by 2028 here

News-ID: 2861733 • Views:

More Releases from Orion Market Research

Aviation Connectors Market By Application Analysis, Regional Outlook, Competitive Strategies And Forecast 2034
Aviation Connectors Market By Application Analysis, Regional Outlook, Competitiv …
The global aviation connectors market was valued at approximately USD 5.6 billion in 2024 and is projected to reach around USD 11.42 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.14% from 2025 to 2034. Aviation Connectors Market Overview The aviation connectors market is experiencing robust growth, driven by the increasing demand for advanced avionics systems and the expansion of both commercial and military aircraft fleets.
Industrial Wastewater Treatment Chemicals Market Development, Industry Trends, Demand and Growth Analysis and Forecasts 2033
Industrial Wastewater Treatment Chemicals Market Development, Industry Trends, D …
The global industrial wastewater treatment chemicals market was valued at approximately USD 19.06 billion in 2024 and is projected to reach around USD 23.6 billion by 2033, growing at a CAGR of 5.4% from 2025 to 2033. Industrial Wastewater Treatment Chemicals Market Overview The global industrial wastewater treatment chemicals market is witnessing significant growth driven by increasing industrialization, stringent environmental regulations, and the growing need for sustainable water management. The
Electronic Adhesives Market Development, Industry Trends, Demand and Growth Analysis and Forecasts 2033
Electronic Adhesives Market Development, Industry Trends, Demand and Growth Anal …
The global Electronic Adhesives Market was valued at approximately USD 5.11 billion in 2024 and is projected to reach USD 8.52 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5.6% between 2025 and 2033. Electronic Adhesives Market Overview The Electronic Adhesives Market is witnessing steady growth, driven by increased adoption of miniaturized electronics, EV components, and consumer gadgets requiring robust bonding, encapsulation, and thermal management. Key
Automotive Interior Materials Market Size Future Scope, Demands and Projected Industry Growths to 2033
Automotive Interior Materials Market Size Future Scope, Demands and Projected In …
The global Automotive Interior Materials Market was valued at approximately USD 62.98 billion in 2024 and is projected to reach USD 91.20 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 4.2% during the period from 2025 to 2033. Automotive Interior Materials Market Overview The Automotive Interior Materials Market is poised for steady expansion, propelled by rising consumer demand for luxury, comfort, and lightweight vehicle interiors. With stringent

All 5 Releases


More Releases for Familial

Homozygous Familial Hypercholesterolemia (HoFH) Market Massive Growth opportunit …
Introduction Homozygous Familial Hypercholesterolemia (HoFH) is a rare genetic lipid disorder characterized by extremely high low-density lipoprotein cholesterol (LDL-C) levels from birth, often exceeding 500 mg/dL. Caused by mutations in both alleles of the LDLR, APOB, or PCSK9 genes, HoFH leads to early-onset atherosclerosis, cardiovascular disease, and premature mortality if untreated. Historically, management relied on lipid-lowering agents, LDL apheresis, and lifestyle modifications. However, the last decade has witnessed a paradigm shift with
Familial Adenomatous Polyposis (FAP) Therapeutics- Pipeline Analysis 2018
Familial adenomatous polyposis (FAP) is a genetic disorder, characterized by the development of adenomatous colon polyps in the intestinal tract, resulting in colon cancer. The disease is diagnosed when more than 100 adenomatous colon polyps are developed in a person. Download the sample report at: https://www.pharmaproff.com/request-sample/1025 A person with FAP is at a high risk of developing cancer of small intestines or stomach. This disease is categorized into three types including attenuated
Heterozygous Familial Hypercholesterolemia (heFH) Therapeutics - Pipeline Analys …
Heterozygous familial hypercholesterolemia (HeFH) is an inherited genetic disorder that affects the body’s ability to control cholesterol. It is characterized by very high LDL (low density lipoprotein) cholesterol (above 190 for adults or above 160 for children) and family history of high cholesterol, heart disease or stroke. Download the sample report @ https://www.pharmaproff.com/request-sample/1135 A very high level of LDL from birth leads to a twenty-fold increase in the risk of premature
Familial Amyloid Cardiomyopathy Treatment Market Opportunity Analysis, 2018–20 …
Aggregation and deposition of mutant and wild-type transthyretin protein (TTR) in heart results in familial amyloid cardiomyopathy, which typically occur after age of 60. Familial amyloid cardiomyopathy is also known as hereditary cardiac transthyretin amyloidosis or hereditary amyloid cardiomyopathy. The protein transthyretin amyloid fibrils infiltrate the myocardium that leads to diastolic dysfunction from restrictive cardiomyopathy, which eventually result to heart failure. There are several mutation in TTR which are associated
Familial Adenomatous Polyposis Pipeline Therapeutics Development Market Review 2 …
RnRMarketResearch.com adds “Familial Adenomatous Polyposis - Pipeline Review, H1 2017” to its store providing an overview of the Familial Adenomatous Polyposis therapeutic pipeline with comprehensive information on the therapeutic development for Familial Adenomatous Polyposis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews
Familial Adenomatous Polyposis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Familial Adenomatous Polyposis - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Familial Adenomatous Polyposis - Pipeline Review, H1 2017, provides an overview of the Familial Adenomatous Polyposis (Genetic Disorders) pipeline landscape. Familial adenomatous polyposis (FAP) is also known as familial polyposis coli, adenomatous polyposis coli, or